Skip navigation

Disease Intellectual Disability

These are exposure studies associated with the disease and all of its children.

Send correction
1–3 of 3 results.
  Reference Associated Study Title Author's Summary Study Factors Stressor Receptors Country Medium Exposure Marker Measurements Outcome
1. Lyall K, et al. (2017). Early Markers for Autism (EMA) | Project Baby's Breath (PBB) The overall pattern of our results suggests increases in risk of autism spectrum disorder and intellectual disability without autism with prenatal exposure to higher levels of a number of organochlorine compounds, particularly polychlorinated biphenyl ethers. 2,2',3,3',4,4',5-heptachlorobiphenyl | 2,2',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl | 2,4,4'-trichlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl | Dichlorodiphenyl Dichloroethylene | nonachlor | PCB 180 | Polychlorinated Biphenyls Controls for disease:Autism Spectrum Disorder | Subjects with disease:Autism Spectrum Disorder | Children | Controls for disease:Intellectual Disability | Subjects with disease:Intellectual Disability | Pregnant females United States serum 2,2',3,3',4,4',5-heptachlorobiphenyl | 2,2',4,4',5-pentachlorobiphenyl | 2,3',4,4',5-pentachlorobiphenyl | 2,4,4'-trichlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl | Dichlorodiphenyl Dichloroethylene | nonachlor | PCB 180 | Polychlorinated Biphenyls Details Autism Spectrum Disorder | Intellectual Disability | Prenatal Exposure Delayed Effects
2. Herbstman JB, et al. (2010). This epidemiologic study demonstrates neurodevelopmental effects in relation to cord blood polybrominated diphenyl ether concentrations. 2,2',4,4',5,6'-hexabromodiphenyl ether | Halogenated Diphenyl Ethers | pentabromodiphenyl ether Infants or newborns United States blood, cord 2,2',3,4,4',5',6-heptabromodiphenyl ether | 2,2',4,4'-tetrabromodiphenyl ether | hexabrominated diphenyl ether 153 | hexabromodiphenyl ether 154 | PBB 153 | pentabromodiphenyl ether Details Intellectual Disability | Psychomotor Disorders | cognition
3. Lyall K, et al. (2018). Early Markers for Autism (EMA) Results from this large case-control study with prospectively collected prenatal measurements do not support the hypothesis that prenatal exposure to per- and polyfluoroalkyl substances is positively associated with autism spectrum disorder or intellectual disability. 2-(N-methylperfluorooctanesulfonamido)acetic acid | hexadecafluoro-nonanoic acid | N-ethyl perfluorooctane sulfonamido acetate | perfluorodecanoic acid | perfluorohexanesulfonic acid | perfluorooctanesulfonamide | perfluorooctane sulfonic acid | perfluorooctanoic acid Subjects with disease:Autism Spectrum Disorder | Children | Subjects with disease:Intellectual Disability | Pregnant females United States serum 2-(N-methylperfluorooctanesulfonamido)acetic acid | hexadecafluoro-nonanoic acid | N-ethyl perfluorooctane sulfonamido acetate | perfluorodecanoic acid | perfluorohexanesulfonic acid | perfluorooctanesulfonamide | perfluorooctane sulfonic acid | perfluorooctanoic acid Details Autism Spectrum Disorder | Intellectual Disability
1–3 of 3 results.